Registry to Document Treatment Effectiveness, Safety, Including Prospective Long-term Outcomes in Participants with Progressive Familial Intrahepatic Cholestasis (PFIC) who take Odevixibat (Bylvay) First published 11/05/2026 Last updated 11/05/2026 EU PAS number:EUPAS1000000975 Study Ongoing